Clinicians' decisions about antibiotic treatment in advanced dementia: an international survey.

IF 2.6 Q3 CLINICAL NEUROLOGY
BMJ Neurology Open Pub Date : 2026-07-31 eCollection Date: 2026-01-01 DOI:10.1136/bmjno-2026-001692
João Pedro Lima, Lawrence Mbuagbaw, Manya Prasad, Amit Kumar, Guy Sadeu Wafeu, Romain Bonnet, Thomas Agoritsas, Sheyu Li, Zhanming Liu, Pablo Alonso-Coello, Fábio Akio Nishijuka, Reza Mirza, Caroline Matos Silva, Rajaa Alshanketi, Imtinan Khalid Alsahafi, Alanood Alnuaimi, Anja Fog Heen, Peter J Mattingly, Sheri A Keitz, Agustin Bengolea, Ariel Izcovich, Surbhi Gupta, Priyanka Aggarwal, Jessyca Matos Silva, Lisa Schwartz, Derek K Chu, Gordon Guyatt
{"title":"Clinicians' decisions about antibiotic treatment in advanced dementia: an international survey.","authors":"João Pedro Lima, Lawrence Mbuagbaw, Manya Prasad, Amit Kumar, Guy Sadeu Wafeu, Romain Bonnet, Thomas Agoritsas, Sheyu Li, Zhanming Liu, Pablo Alonso-Coello, Fábio Akio Nishijuka, Reza Mirza, Caroline Matos Silva, Rajaa Alshanketi, Imtinan Khalid Alsahafi, Alanood Alnuaimi, Anja Fog Heen, Peter J Mattingly, Sheri A Keitz, Agustin Bengolea, Ariel Izcovich, Surbhi Gupta, Priyanka Aggarwal, Jessyca Matos Silva, Lisa Schwartz, Derek K Chu, Gordon Guyatt","doi":"10.1136/bmjno-2026-001692","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>In patients living with advanced dementia, the intensity of care during life-threatening infections remains controversial and marked by wide variation in practice. This international survey investigated physicians' and physicians-in-training's management choices for individuals with advanced dementia and the factors associated with those choices.</p><p><strong>Design: </strong>Vignette-based survey.</p><p><strong>Setting: </strong>Twelve countries across five continents.</p><p><strong>Methods: </strong>We administered our vignette-based survey to medical students, residents and physicians. The survey elicited participants' views on whether antibiotics should be administered to an elderly patient with advanced dementia and very poor quality of life, presenting with bacterial pneumonia. We explored factors associated with treatment choices using univariable analysis and multiple logistic regression models.</p><p><strong>Results: </strong>Of the 785 participants (age, mean (SD): 31.1 (11.5) years), one-third (31.2%) resided in the Region of the Americas, 21.9% in Europe, 16.2% in the Eastern Mediterranean region and 17.1% in China. In the univariable analysis, choice to treat was associated with younger age, country/WHO region (African region highest overall, European region lowest overall), stage of medical training (medical student most inclined to treat) and absence of medical assistance in dying (MAiD) legislation. Multivariable analyses provided evidence that country was the variable most strongly associated with the choice to treat with antibiotics (Cameroon, China, Saudi Arabia highest; Norway, Switzerland, Spain lowest), with the presence of MAiD legislation also strongly associated (OR 0.35, 95% CI 0.23 to 0.51). Age (OR 0.82, 95% CI 0.66 to 1.00) and religiosity level (OR 0.93, 95% CI 0.87 to 0.99) showed weaker associations with treatment decisions.</p><p><strong>Conclusion: </strong>Inclination to treat individuals with advanced dementia who develop pneumonia varies greatly between and within jurisdictions. Social factors (in particular country but also presence of MAiD legislation) proved the most prominent associations, with individual characteristics much less influential. These findings underscore the importance of contextual and cultural factors in value-sensitive clinical decisions.</p><p><strong>Registration: </strong>We registered the protocol at Open Science Framework (osf.io/6kfbt).</p>","PeriodicalId":52754,"journal":{"name":"BMJ Neurology Open","volume":"8 2","pages":"e001692"},"PeriodicalIF":2.6000,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13435922/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Neurology Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjno-2026-001692","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: In patients living with advanced dementia, the intensity of care during life-threatening infections remains controversial and marked by wide variation in practice. This international survey investigated physicians' and physicians-in-training's management choices for individuals with advanced dementia and the factors associated with those choices.

Design: Vignette-based survey.

Setting: Twelve countries across five continents.

Methods: We administered our vignette-based survey to medical students, residents and physicians. The survey elicited participants' views on whether antibiotics should be administered to an elderly patient with advanced dementia and very poor quality of life, presenting with bacterial pneumonia. We explored factors associated with treatment choices using univariable analysis and multiple logistic regression models.

Results: Of the 785 participants (age, mean (SD): 31.1 (11.5) years), one-third (31.2%) resided in the Region of the Americas, 21.9% in Europe, 16.2% in the Eastern Mediterranean region and 17.1% in China. In the univariable analysis, choice to treat was associated with younger age, country/WHO region (African region highest overall, European region lowest overall), stage of medical training (medical student most inclined to treat) and absence of medical assistance in dying (MAiD) legislation. Multivariable analyses provided evidence that country was the variable most strongly associated with the choice to treat with antibiotics (Cameroon, China, Saudi Arabia highest; Norway, Switzerland, Spain lowest), with the presence of MAiD legislation also strongly associated (OR 0.35, 95% CI 0.23 to 0.51). Age (OR 0.82, 95% CI 0.66 to 1.00) and religiosity level (OR 0.93, 95% CI 0.87 to 0.99) showed weaker associations with treatment decisions.

Conclusion: Inclination to treat individuals with advanced dementia who develop pneumonia varies greatly between and within jurisdictions. Social factors (in particular country but also presence of MAiD legislation) proved the most prominent associations, with individual characteristics much less influential. These findings underscore the importance of contextual and cultural factors in value-sensitive clinical decisions.

Registration: We registered the protocol at Open Science Framework (osf.io/6kfbt).

临床医生对晚期痴呆症抗生素治疗的决定:一项国际调查。
目的:在患有晚期痴呆的患者中,在危及生命的感染期间的护理强度仍然存在争议,并且在实践中存在很大差异。这项国际调查调查了医生和实习医生对晚期痴呆症患者的管理选择以及与这些选择相关的因素。设计:基于插图的调查。背景:横跨五大洲的12个国家。方法:我们对医学生、住院医师和医生进行了基于小视频的调查。该调查引发了参与者对是否应该对患有晚期痴呆症和生活质量非常差的老年患者使用抗生素的看法,这些患者表现为细菌性肺炎。我们使用单变量分析和多元逻辑回归模型探讨了与治疗选择相关的因素。结果:在785名参与者(年龄,平均(SD): 31.1(11.5)岁)中,三分之一(31.2%)居住在美洲地区,21.9%居住在欧洲,16.2%居住在东地中海地区,17.1%居住在中国。在单变量分析中,选择治疗与年龄更小、国家/世卫组织区域(非洲区域总体最高,欧洲区域总体最低)、医学培训阶段(医学生最倾向于治疗)和缺乏死亡医疗援助(MAiD)立法有关。多变量分析提供的证据表明,国家是与抗生素治疗选择最密切相关的变量(喀麦隆、中国、沙特阿拉伯最高;挪威、瑞士、西班牙最低),MAiD立法的存在也密切相关(OR 0.35, 95% CI 0.23至0.51)。年龄(OR 0.82, 95% CI 0.66 ~ 1.00)和宗教信仰水平(OR 0.93, 95% CI 0.87 ~ 0.99)与治疗决定的相关性较弱。结论:不同地区对发展为肺炎的晚期痴呆患者的治疗倾向差异很大。社会因素(特别是国家,但也包括MAiD立法)证明了最显著的关联,个人特征的影响要小得多。这些发现强调了语境和文化因素在价值敏感的临床决策中的重要性。注册:我们在开放科学框架(osf.io/6kfbt)上注册了该协议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMJ Neurology Open
BMJ Neurology Open Medicine-Neurology (clinical)
CiteScore
3.20
自引率
3.70%
发文量
46
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书